Clincosm LogoSign in Get a demo

Glioblastoma Multiforme

Showing NaN - NaN of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)

Recruiting
  • Glioblastoma Multiforme
  • Perillyl alcohol
  • Los Angeles, California
  • +1 more
Sep 23, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

Not yet recruiting
  • Glioblastoma Multiforme
  • Glioblastoma
  • IGV-001 Cell Immunotherapy
  • +3 more
  • Newark, Delaware
  • +22 more
Jun 24, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • MGMTP140K-encoding retroviral vector
  • +6 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Glioblastoma Multiforme Trial in India, United States (Lucanthone, Temozolomide (TMZ), Radiation)

Terminated
  • Glioblastoma Multiforme
  • La Jolla, California
  • +9 more
Oct 18, 2021

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor Trial in Cleveland (AutoLITT system)

Completed
  • Brain Tumor
  • +5 more
  • AutoLITT system
  • Cleveland, Ohio
  • +1 more
Aug 23, 2021

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Glioblastoma Multiforme, Astrocytoma, Gliomas, Malignant Trial in United States (Toca 511 vector, Toca FC • Flucytosine • 5-FC •

Terminated
  • Glioblastoma Multiforme
  • +2 more
  • Toca 511 vector
  • Toca FC • Flucytosine • 5-FC • 5-Fluorocytosine
  • Los Angeles, California
  • +10 more
Mar 26, 2020

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)

Terminated
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Toca 511
  • +4 more
  • Phoenix, Arizona
  • +66 more
Feb 6, 2020

Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)

Completed
Has Results
  • Glioblastoma Multiforme
  • poly ICLC
  • +2 more
  • Birmingham, Alabama
  • +8 more
May 30, 2019

Glioblastoma, Glioblastoma Multiforme Trial in Cincinnati, Cleveland, Columbus (TRC105, Bevacizumab)

Completed
Has Results
  • Glioblastoma
  • Glioblastoma Multiforme
  • Cincinnati, Ohio
  • +3 more
May 21, 2019

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Boston, Detroit, Cleveland (PF-00299804)

Completed
  • Glioblastoma
  • +2 more
  • Boston, Massachusetts
  • +3 more
Aug 14, 2018

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511
  • Toca FC
  • Irvine, California
  • +5 more
May 16, 2018

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Toca 511 vector
  • Toca FC
  • Los Angeles, California
  • +7 more
May 16, 2018

Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

Completed
  • Adult Brain Glioblastoma
  • Glioblastoma Multiforme
  • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
  • Bevacizumab
  • Birmingham, Alabama
  • +15 more
Jan 24, 2018

Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)

Completed
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +88 more
Apr 7, 2017

Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)

Completed
Has Results
  • Glioblastoma Multiforme
  • ICT-107
  • Placebo DC
  • South Birmingham, Alabama
  • +24 more
Feb 10, 2017

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (IL13-PE38QQR, targeted fusion protein

Completed
  • Malignant Glioma
  • +3 more
  • Birmingham, Alabama
  • +7 more
Nov 12, 2014

Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (XL765 (SAR245409), Temozolomide)

Completed
  • Mixed Gliomas
  • +2 more
  • Birmingham, Alabama
  • +5 more
Apr 9, 2013

Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma Trial in United States (IL13-PE38QQR, Surgery for placement,

Completed
  • Glioblastoma Multiforme
  • +2 more
  • San Francisco, California
  • +5 more
Jun 30, 2011

Glioblastoma Multiforme Trial in Worldwide (IL13-PE38QQR, surgery and catheter placement (2 procedures), prolifespan 20 with

Completed
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +59 more
Jun 2, 2011

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Germany, Israel, United States (IL13-PE38QQR,

Completed
  • Malignant Glioma
  • +3 more
  • Denver, Colorado
  • +5 more
Jun 2, 2011